Seeking Alpha
 

Milestone Scientific Inc. (MLSS)

- OTCQB
  • Nov. 13, 2014, 10:13 AM
    • Milestone Scientific (OTCQB:MLSS) will report Q3 results on November 17 after the close. The conference call will begin at 4:30 pm ET.
    • Consensus view for revenue is $2.7M.
    | Comment!
  • Sep. 18, 2014, 8:21 AM
    • Milestone Scientific (OTCQB:MLSS) subsidiary Milestone Medical receives CE Mark clearance for its CompuFlo Epidural Computer Controlled Anesthesia System (CompuFlo Epidural Model 6000). The device verifies the needle tip placement  in the lumbar epidural space in patients at least 18 years of age and the delivery of medication and other fluids in a controlled manner in the lumbar epidural space in either an in-patient or out-patient setting.
    • The system's core technology is called Dynamic Pressure Sensing (DPS). It measures the density of body tissue in order to assist the clinician in locating a hypodermic needle during an injection.
    | Comment!
  • Sep. 15, 2014, 10:56 AM
    • Milestone Scientific (OTCQB:MLSS +7%) earns CE Mark clearance for its CompuFlo System for intra-articular injections. The product's injection technology is called Dynamic Pressure Sensing. It measures the density of body tissue to help the clinician locate a hypodermic needle during an injection.
    • The company's European subsidiary is moving forward with engaging a distribution partner.
    | Comment!
  • Aug. 14, 2014, 11:18 AM
    • Milestone Scientific (OTCQB:MLSS) Q2 results: Revenues: $2.5M (+10.0%); Operating Expenses: $1.5M (+11.9%); Net Loss: ($0.2M) (-329.1%); Loss Per Share: ($0.01); Quick Assets: $10.6M (+863.6%).
    • No financial guidance given.
    | Comment!
  • May. 27, 2014, 8:51 PM
    • Milestone Scientific (MLSS) appoints Gian Domenico Trombetta CEO of its dental division. Mr. Trombetta will also serve as a member of the board of directors. He is the President and CEO of Innovest S.p.A., a Milan-based private equity and special situation investment company. His appointment follows a $10M investment in the firm led by Innovest.
    • Leonard Osser will remain CEO of MLSS.
    | Comment!
Visit Seeking Alpha's
MLSS vs. ETF Alternatives
Company Description
At Milestone Scientific, we are passionate about revolutionizing the doctor and patient injection experience. Since 1995, our commitment to advancing the science of computer-controlled drug delivery technologies has earned us global distinction as an industry leader and pioneering innovators in... More